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ABSTRACT (Maximum 200 words)
The systemic uptake of chloroform from dilute aqueous solutions into live hairless rats under conditions simulating dermal environmental exposure was studied. Whole blood was sampled during a 30-minute immersion of an animal within water containing a known concentration of chloroform and then for 5.5 hours following its removal from the bath. The amount of chloroform systemically absorbed was determined by comparing the AUCs of the blood concentration versus time plots from dermal exposure to that obtained after IV infusion (for a period of 30 minutes) of an aqueous solution containing a known amount of chloroform (positive control). Although dermal data implied 2-compartment disposition characteristics, IV infusion data fit best to a 3-compartment disposition. Linear pharmacokinetics was observed both by IV administration and percutaneous absorption at the dose levels studied. Chloroform was detected in the rat blood as early as 4 minutes following exposure. Our findings suggest that about 10.2 mg of chloroform was systemically absorbed after dermal exposure of a rat to an aqueous solution of 0.44 mg/ml. This amount is substantially higher than the predictions of risk models put forth by other investigators. Reasonable agreement existed between a past estimate of uptake based on depletion of bath level of chloroform and the actual uptake measured in these experiments. The estimated onset of systemic entry seen here is entirely consistent with our estimate of how long it takes to establish the diffusion gradient across the stratum corneum based on tape stripping. 
PAGE
Blood concentration-time profiles for chloroform after IV infusion of 19 mg (in 5 ml aqueous solution) over 30 min and after dermal exposure of the hairless rats to a 0.44 mg/ml aqueous solution for 30 min at 36°C. Each data point represents average (± SE) of four experiments
16
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INTRODUCTION
Recently, there has been a growing concern about the cumulative absorption of chemicals from frequent, intermittent, brief exposures to contaminated water, as might occur daily through bathingO). For the most part, such exposures fall short of diffusion lag times for permeation of the skin, which range from several minutes for low molecular weight compounds to several hours for heavier ones @) and the question has been raised if it is appropriate to use steady-state absorption algorithms to quantify such exposures. The temporal dependencies of the exposures therefore have to be resolved. Chloroform is a representative low molecular weight, lipophilic, very volatile, halogenated compound which is present as a pollutant in our water supplies, and thus a good compound to use to evaluate the unresolved issues. This chemical can be acutely toxic and is also a suspect carcinogen w). Therefore, the health risk arising from frequent, brief
showering/swimming of human beings in water containing it as a contaminant can not be ignored, especially considering the large surface area of skin which might be exposed.
Although some literature exists on the determination of blood level of chloroform in nonoccupationaUy exposed humans (4-7) and fo animals (°), the means of its intake has generally been other than dermal. Jorgenson and Rushbrook's (°) 90-day subacute study in male rats and female mice, for instance, was aimed at providing toxicologic and range-finding data sufficient for setting dose levels for the chronic-phase testing of chloroform in drinking water. While all of these studies offer important insights concerning chloroform's uptake, none deals totally effectively with the question of the non-stationary character of uptake associated with very brief exposures.
Earlier ( 13 ) we reported on the fate of chloroform taken up into hairless rat skin in the course of exposure to a well-stirred dilute aqueous solution of the chemical. The total dermal uptake was estimated by difference in the bath water concentration of chloroform with and without a rat being present Measured indirectly, a significant amount of chloroform appeared to reach the viable epidermis and its underlying systemic circulation with exposure times as short as 4 min. The total amount absorbed in a 30-min exposure was estimated to be 29.4 mg. Like studies before it, the indirect method of estimation leaves such conclusions subject to question.
To clarify these issues, blood chloroform concentrations arising from short exposure of hairless rats to a dilute aqueous solution have been determined and are reported here.
MATERIALS AND METHODS
Materials and Animals: HPLC grade chloroform (ChromAR® HPLQ was obtained form
Mallincrodt, Inc., St. Louis, Missouri. It contained 99% chloroform with 1% ethanol added for stabilization. Hexane used for extraction of chloroform from rat blood was purchased from Fisher Scientific. It was OPTIMA grade and met the rigid analytical requirements for use in electron capture gas chromatography and for residue and pesticide analysis. Since the animals were anesthetized during the experiments, an isothermal pad (Deltaphase™, Braintree Scientific, Inc., Brainlree, Massachusetts) was placed beneath them to provide warmth while out of the bath.
The male hairless rats (CRL:CD) used in the experiments were obtained from Charles River
Laboratories, Raleigh, North Carolina. They were 15-20 weeks old, weighing between 410 to 535 g.
Bath Assembly for Hairless Rats:
A tall, 1000 ml, jacketed glass beaker formed the bath in which sedated animals were immersed. This beaker supported a restraining collar (made of stainless steel) used to keep the animal's head above the water and to provide an isolated air environment around the head from which the animal breathed. To accomplish the latter objective, the animal's head was enclosed in a glass chamber formed from an inverted beaker.
The rim of this glass chamber fitted into a cylindrical groove, 66 mm in diameter, 4 mm wide and about 2 mm deep, notched into the collar. Air was forced into the chamber through a portal placed over the animal's head. Three symmetrically placed notches across the groove allowed excess to escape at the level of the neck. A photograph of the setup and dimensional details are given our previous paper (*3). A stainless steel rack was placed at the bottom of the beaker to support the rat and allow stirring by a magnetic stirrer placed at the bottom of the vessel. The bath water temperature was held constant at 36 ± 0.2°C (nominally the skin-surface temperature of the rat) using a circulating water bath (Lauda Model M3-B). The entire apparatus was placed inside a fume hood to contain all escaping chloroform.
Preparation of the Aqueous Solution of Chloroform
Dermal Exposure Solution:
Solutions of chloroform in deionized water at 36°C were prepared by adding a calculated volume (0.205 mL) of chloroform to 450 ml of pre-warmed water in a 1000 ml separatory funnel and then vigorously shaking the water for about 2 minutes.
Droplets of chloroform at the bottom of the funnel disappeared within this time. This technique ensured complete solution of the test substance and a reproducible initial concentration of 0.44 mg/ml, a concentration 3 orders of magnitude higher than the upper limit of the U. S. EPA toxicity threshold (0.47 Hg/ml) ( 14 X
Positive Control Solution:
For the IV experiments, 57 mg (38.41 ul) of chloroform was dissolved in IG ml of deionized water at 36°C in a 20 ml glass scintillation vial. This solution contained 38 mg (assayed quantity) of chloroform in 10 ml, corresponding to about 50% saturation. Five ml of this solution containing 19 mg of chloroform were intended to be infused into the rat over a 30 min period 2.4. Animal Preparation:
Anesthesia:
A combination of Ketamine hydrochloride (87 mg/kg) and Xylazine hydrochloride (13 mg/kg), both given intramuscularly, kept a hairless rat in a sedated state for about 2.5 hours. A second injection was necessary since blood sampling was continued for up to 6 hours. The animals were anesthetized to set the canulae and kept in this state over the entire period of blood sampling.
Jugular Vein Canulation:
Because frequent blood sampling took place during the experiments, canulation was done to reduce the stress to the animals. The right jugular vein only was canulated when the rat was dermally exposed to the immersion chamber because only withdrawal of blood samples was required. However, both the right and the left veins had to be the ventral skin of the rat above the shoulder was cleaned with an alcohol swab and a vertical, 2 cm long incision was made. After locating the vein, the adjacent connective tissue was cleared away and the canula was inserted through the small cut made into the vein by a slanted needle while lifting the vein slightly. The canula was pushed inward towards the heart until blood was seen in the tubing upon pulling back the 1 cc syringe plunger. Some of the heparinized saline was then injected back towards the heart; the syringe was left in place to prevent clotting.
Finally, the incision was closed with silk suture.
Exactly the same procedure was followed in canulating the left jugular vein. In order to facilitate the IV infusion of the chloroform solution from an infusion pump into a rat positioned inside the bath, a second piece of polyethylene tubing, about 11" long, was joined to the existing piece through an union made out of the shaft of a 20 G needle. California, USA was used. Nitrogen was used as the carrier gas with a total flow rate of 120 ml/min (purge vent 20 ml/min, split vent 50 ml/min and column 50 ml/min) and the column head pressure was maintained at 9 psig. The column, the injector and the detector temperatures were set at 65°C, 100°C and 120°C, respectively.
Calibration curves were prepared weekly by plotting the peak areas obtained on injection of 1 pJ of the standard solutions against the known concentrations of chloroform in pure hexane.
This calibration method was decided upon after extensive work on the assay (to be published separately). One microliter of the clear extract (top hexane layer) of each sample was directly injected into the GC column. The injection was repeated at least two times per sample. The magnetic sample insert of the autosampler was modified to make the injector syringe sample the hexane layer without touching the drop of blood at the bottom of the vial. Between injections the GC injector syringe was rinsed twice with the next sample. Concentrations in the blood samples were determined by dividing the peak areas by the slope of the calibration curve. The standard curves were linear from 10 -4000 pg/pJ and passed through the origin.. Extraction efficiency was determined by equilibrating a series of chloroform-in-hexane solutions with 100 pJ of rat blood in 2 ml GC autosampler vials and expressing the chloroform concentration in the hexane layer found after equilibration as the percent recovered. This proved to be near 100% at concentrations > 100 pg/|il and ranged between 75 and 100% from about 10 to 100 pg/p.1.
RESULTS AND DISCUSSION
Blood profiles obtained upon infusing 19 mg of chloroform at a steady rate into the jugular vein over 30 min and also after whole body exposure (up to the neck) of a separate set of rats for the same period to a 36°C aqueous solution of chloroform initially containing 0.44 mg/ml of the test pollutant are provided in Figure 1 . These curves are composits of the data obtained with 4 animals in cases of both IV infusion and aqueous immersion. The first notable aspect of the profiles is that more than 30 min of steady infusion is obviously necessary to achieve a steady blood level. In other words, neither the IV infusion nor the percutaneous absorption curves reached a peak at the 30-min terminus of the exposure. It is also evident from the inset of Figure   1 that blood levels achieved as the result of dermal absorption lag only a little behind those with rv infusion. The blood levels are very sensitive to input and drop immediately upon cessation of the infusion/exposure processes. In a previous study in which tape stripping was used to measure chloroform in the surface of the skin (^\ it was concluded that the gradient of diffusion of chloroform across the stratum corneum is established within 8 min or less, the best estimate by this means being about 4 min. It is evident from the inset plot of Figure 1 that the lag time for systemic breakthrough, that is, the time to systemic entry, is on the order of 4 min by pharmacokinetic analysis. This is a highly satisfying level of agreement between these remarkably different means of estimation.
In order to elucidate the compartmental characteristics of chloroform's absorption and elimination, the natural logarithms of the blood concentrations were plotted against time, as shown in Figure 2 . Linear pharmacokinetcs was apparent at the dose levels studied in that neither of the curves shows concavity towards the time axis. At the risk of slightly overprocessing these data, the dermal exposure curve evidences one inflection point indicating a two compartmental disposition following percutaneous input. The IV infusion curve, however, actually evidences two inflection points, implying a three compartmental disposition pattern may exist. These essential features were confirmed by applying the method of residuals to both curves 05). The terminal elimination rate constants (K, min"!) shown in Table I were calculated using the last four data points from each curve. For the dermal exposure, the first-order input rate constant (K a , min'l) and the first post-absorptive hybrid rate constant (oc, min"*), each listed in Table I , were calculated by the method of residuals. In the instance of IV infusion, the first post-absorptive hybrid rate constant (a, min -*) could not be determined because of an insufficiency of data points. A value for this of 0.16 min'l was achieved by overall best-fit analysis, however. PCNONLIN Nonlinear Estimation Program (version 4.2) (16) wa s used to fit the experimental data to the appropriate models with tbe blood concentration data being weighted by a factor of 1/concentration. Values for all these rate constants by both methods of estimation are found in Table I min. This peak appears 1 to 3 minutes later for the data obtained via skin permeation. This slight shift, though not statistically separable, is actually expected because the skin acts as a reservoir for chloroform for a short period. Stripping data indicate this reservoir is depleted in but a few minutes (13) . Also, regardless of which set of data is used and how the calculations are done, the terminal elimination rate constants are all in good agreement, lying between 0.005 and 0.011 min" 1 .
The areas under the curves (AUCs) were calculated for the blood concentration-time profiles using the trapezoidal rule (15) . To obtain AUCo-oo, the area from the last concentration datum point, C n , to infinity was set equal to Cn/K and this was added to the area, AUC0-C nThese parameters too are listed in Table I . The best-fit estimates in the Table are (21) .
Since our prime objective in this study was to assess the chloroform body burden arising from its systemic uptake during an exposure to a dilute aqueous solution, we utilized the AUC after IV infusion as the reference standard to quantitate the amount of chloroform absorbed over the 30 min of expsure. We decided to put this calculated systemic uptake value in Table H alongside our previously reported total uptake found by difference by direct sampling of the bath water (13) as well as the values predicted by risk assessment models suggested by other investigators (22) (23) (24) . Although we determined the systemic uptake only after 30 min exposure in this study by simply using the ratio of AUCs after IV infusion and dermal exposure, the same technique would provide proportional values for shorter dermal exposure times. It is clear that the systemic uptake of chloroform as determined by blood sampling is about three times higher than what we previously found by following the depletion of chloroform from the bath water with and without a rat present. Local tissue binding of chloroform likely plays a role in this quantitative discrepancy. In fact, early investigations confirmed that administration of chloroform to rodents results in a high degree of irreversible binding of nonvolatile metabolites, predominantly in the surface epithelia of the respiratory and upper alimentary tracts and also to a significant extent in the liver and kidney (25) (26) (27) . Therefore, it is reasonable to assume that the AUC from the blood level of unmetabolized chloroform versus time data in our study underestimates, to some extent, the actual amount of chloroform inside the hairless rat's body.
The systemic uptake of chloroform found in this study, however, is badly underestimated by the various models put forth by other investigators (22) (23) (24) Tnis observation clearly indicates that, irrespective of the literature method used to quantitate the body burden of chloroform after dermal exposure to a dilute aqueous solution, the actual risk is far higher. It seems fair to say that these models should be revisited and reworked in light of the present data. Found by direct blood sampling. 
